Oscar Health (NYSE:OSCR) Raised to "Strong-Buy" at Wall Street Zen

Oscar Health (NYSE:OSCR - Get Free Report) was upgraded by stock analysts at Wall Street Zen from a "hold" rating to a "strong-buy" rating in a research report issued on Saturday.

A number of other brokerages have also recently weighed in on OSCR. UBS Group increased their price target on shares of Oscar Health from $15.00 to $20.00 and gave the stock a "neutral" rating in a research note on Thursday. Wolfe Research assumed coverage on shares of Oscar Health in a research note on Tuesday. They issued a "peer perform" rating for the company. Barclays raised their target price on shares of Oscar Health from $18.00 to $21.00 and gave the stock an "equal weight" rating in a research note on Thursday. Jefferies Financial Group upgraded shares of Oscar Health from an "underperform" rating to a "hold" rating and raised their target price for the stock from $10.00 to $16.00 in a research note on Monday, April 20th. Finally, Robert W. Baird increased their price target on shares of Oscar Health from $15.00 to $19.00 and gave the company a "neutral" rating in a report on Thursday. Two equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and two have given a Sell rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus price target of $18.22.

Oscar Health Price Performance

Oscar Health stock opened at $21.28 on Friday. The company's 50 day simple moving average is $14.43 and its 200-day simple moving average is $15.29. The company has a market capitalization of $6.34 billion, a price-to-earnings ratio of -36.07, a price-to-earnings-growth ratio of 2.78 and a beta of 2.34. Oscar Health has a 1 year low of $10.69 and a 1 year high of $23.80. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.96 and a current ratio of 0.96.

Oscar Health (NYSE:OSCR - Get Free Report) last released its quarterly earnings results on Wednesday, May 6th. The company reported $2.07 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.11 by $0.96. The business had revenue of $4.65 billion for the quarter, compared to the consensus estimate of $4.90 billion. Oscar Health had a negative net margin of 0.30% and a negative return on equity of 3.73%. The business's revenue was up 52.6% on a year-over-year basis. During the same period in the previous year, the firm earned $0.92 EPS. As a group, equities research analysts expect that Oscar Health will post 0.25 earnings per share for the current year.

Insider Activity

In other news, CEO Mark T. Bertolini purchased 1,000,000 shares of the firm's stock in a transaction on Monday, April 6th. The shares were bought at an average cost of $11.92 per share, with a total value of $11,920,000.00. Following the purchase, the chief executive officer directly owned 10,196,876 shares of the company's stock, valued at approximately $121,546,761.92. This trade represents a 10.87% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 24.39% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. Udine Wealth Management Inc. increased its stake in shares of Oscar Health by 138.4% in the third quarter. Udine Wealth Management Inc. now owns 146,555 shares of the company's stock worth $2,774,000 after buying an additional 85,083 shares during the last quarter. Q Fund Management Hong Kong Ltd acquired a new stake in Oscar Health in the third quarter worth about $5,940,000. State of Michigan Retirement System acquired a new stake in Oscar Health in the third quarter worth about $27,448,000. Vanguard Group Inc. lifted its holdings in Oscar Health by 2.1% in the third quarter. Vanguard Group Inc. now owns 20,160,399 shares of the company's stock worth $381,636,000 after purchasing an additional 423,184 shares during the period. Finally, Farallon Capital Management LLC lifted its holdings in Oscar Health by 146.5% in the third quarter. Farallon Capital Management LLC now owns 3,639,000 shares of the company's stock worth $68,886,000 after purchasing an additional 2,163,000 shares during the period. 75.70% of the stock is owned by institutional investors and hedge funds.

Oscar Health Company Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company's primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.